Air vs. Cutaneous Control Mode for Preterm Infants ≤ 32 WG in Incubators: Impact on Body Growth and Morbidity

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Apr 15, 2019

Keywords

ClinConnect Summary

This clinical trial is investigating how different methods of controlling temperature in incubators can affect the growth and health of preterm infants born between 25 and 32 weeks of gestation. The researchers want to find out if using a special software that calculates the best air temperature for each baby can help them grow better during their first 10 days of life, compared to a traditional method that uses skin temperature as a guide. The study aims to see if this new approach can also reduce health problems that preterm infants often face.

To be part of this study, infants must be born very early (between 25 and 32 weeks) and be included in the trial within the first day of their lives. They will be cared for in a closed incubator, and parents will need to give their written consent for their baby's participation. The researchers hope to enroll several infants and will monitor their growth and health closely throughout the trial. This study could provide valuable information on how to better care for preterm babies and improve their chances of healthy development.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • preterm infant born between 25+0 and 32+0 weeks of gestation
• • preterm infant included in the study before 24 +/- 12 hours of life
• • preterm infant nursed in a closed incubator
• • written informed consent from his parents
• Exclusion Criteria:
• • newborn infant with polymalformative syndrome
• • life threatening events or serious heart disease